• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG FLUENCY PLUS VASCULAR STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG FLUENCY PLUS VASCULAR STENT GRAFT Back to Search Results
Catalog Number FVM14120
Device Problems Positioning Failure (1158); Fracture (1260); Misfire (2532)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/24/2017
Event Type  malfunction  
Manufacturer Narrative
No medical records or no medical images have been made available to the manufacturer.As the lot number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.The product catalog number identified has not been cleared in the us, but is similar to the fluency plus endovascular stent graft products that are cleared in the us.
 
Event Description
It was reported that the vascular stent allegedly partially deployed; therefore, a second device was used to complete the procedure.There was no reported patient injury.
 
Manufacturer Narrative
New information provided revealed that the reported date of awareness was incorrect.The event information was reported to the dealer/distributor (a non-bard entity) on (b)(6) 2017; however, the dealer/distributor did not report the event to a bard employee until (b)(6) 2017.Therefore, the date of awareness and the emdr date of awareness were updated to (b)(6) 2017.Manufacturing review: the lot history records have been reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.The review showed that no remarkable incidents occurred during the manufacturing process.No additional complaint has been reported for this lot number previously investigation summary: on the basis of the returned stent graft delivery system, the alleged deployment failure could be confirmed.The stent graft was found to be partially released.The outer sheath was found to be elongated over the entire length, which indicated that a high deployment force was present during the deployment attempt which subsequently resulted in an outer sheath fracture.As a result of the investigation performed the complaint was confirmed.Based on the available information and the evaluation of the returned sample, a definite root cause for the reported event could not be determined.Labeling review: in reviewing the labeling supplied with this product it was found that the instructions for use (ifu) sufficiently address the potential risks.Regarding preparation of the device and the patient anatomy the ifu states that "prior to loading the vascular system over a guide wire, both ports must be flushed with sterile saline (.).Flushing these lumens will also facilitate stent graft deployment." and "predilatation of the stenosis may be performed prior to stent graft deployment at the discretion of the physician." the ifu states: "prior to stent graft deployment (.), ensure that the proximal stent graft end is positioned in a straight section of the lumen to reduce the risk of increased deployment forces and possible failure to deploy." furthermore, the ifu states: "the sterile packaging and devices should be inspected prior to use.Verify that the packaging and the device are undamaged and that the sterile barrier is intact.If damaged, do not use.".
 
Event Description
It was reported that a vascular stent allegedly partially deployed so, a second device was used and this device also partially deployed.Therefore, a third device was used in order to complete the procedure.There was no reported patient injury.
 
Manufacturer Narrative
The lot history records have been reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.The review showed that no remarkable incidents occurred during the manufacturing process.No additional complaint has been reported for this lot number previously on the basis of the returned stent graft delivery system, the alleged deployment failure could be confirmed.The stent graft was found to be partially released.The outer sheath was found to be elongated over the entire length, which indicated that a high deployment force was present during the deployment attempt which subsequently resulted in an outer sheath fracture.As a result of the investigation performed the complaint was confirmed.Based on the available information and the evaluation of the returned sample, a definite root cause for the reported event could not be determined.In reviewing the labeling supplied with this product it was found that the instructions for use (ifu) sufficiently address the potential risks.Regarding preparation of the device and the patient anatomy the ifu states that "prior to loading the vascular system over a guide wire, both ports must be flushed with sterile saline.Flushing these lumens will also facilitate stent graft deployment." and "predilatation of the stenosis may be performed prior to stent graft deployment at the discretion of the physician." the ifu states: "prior to stent graft deployment, ensure that the proximal stent graft end is positioned in a straight section of the lumen to reduce the risk of increased deployment forces and possible failure to deploy." furthermore, the ifu states: "the sterile packaging and devices should be inspected prior to use.Verify that the packaging and the device are undamaged and that the sterile barrier is intact.If damaged, do not use." (date of awareness changed on new information received: (b)(6) 2017).
 
Event Description
It was reported that a vascular stent allegedly partially deployed so, a second device was used and this device also partially deployed.Therefore, a third device was used in order to complete the procedure.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLUENCY PLUS VASCULAR STENT GRAFT
Type of Device
VASCULAR STENT GRAFT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM  76227
Manufacturer (Section G)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM   76227
Manufacturer Contact
judith ludwig
1625 w 3rd st.
tempe, AZ 85281
4803032689
MDR Report Key6885046
MDR Text Key88230322
Report Number9681442-2017-00269
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
Reporter Country CodeSI
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Reporter Occupation Radiologic Technologist
Type of Report Initial,Followup,Followup
Report Date 11/20/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/21/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2018
Device Catalogue NumberFVM14120
Device Lot NumberANZK3854
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/11/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/17/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/21/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-